Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts
Allergologia et Immunopathologia · 2024
DOI: 10.15586/aei.v52i4.1111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Jie Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China. Hauptthemen laut MEDLINE: Cell Proliferation, Berberine, Myofibroblasts, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Pulmonary fibrosis (PF) is a chronic, progressive, and irreversible heterogeneous disease of lung interstitial tissue. To combat progression of PF, new drugs are required to be developed. Rhizoma coptidis (COP), one of the main alkaloids of Coptis chinensis, is a traditional herbal medicine used to treat various inflammatory diseases.
Objective
To investigate the possible effects of Coptisine (Cop) on the growth, inflammation, as well as FMT of TNF-β1-induced HFL1 cells and uncover the mechanism. Material and Methods: Human fetal lung fibroblast 1 (HFL1) was induced using 6ng/mL TGF-β1 as a model of pulmonary fibrosis. CCK-8, Brdu, and transwell assays indicated the effects on cell growth as well as motility. qPCR and the corresponding kits indicted the effects on cell inflammation. Immunoblot showed the effects on FMT and further confirmed the mechanism.
Results
Coptisine inhibits excessive growth as well as motility of TNF-β1-induced HFL1 cells. It further inhibits inflammation and ROS levels in TNF-β1-induced HFL1 cells. Coptisine inhibits the FMT process of TNF-β1-induced HFL1 cells. Mechanically, coptisine promotes the Nrf2/HO-1 pathway.
Conclusion
Coptisine can inhibit the excessive growth, inflammation as well as FMT of lung fibroblasts into myofibroblasts. It could serve as a promising drug of PF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China.
- Department of Radiotherapy, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China; yth_0417@163.com.
Zitieren
APA
Yang, J., Huang, Y., Cui, Z., Liu, C., & Xie, G. (2024). Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i4.1111
Vancouver
Yang J, Huang Y, Cui Z, Liu C, Xie G. Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i4.1111
BibTeX
@article{Yang2024,
author = {Yang, Jie and Huang, Yuting and Cui, Zhimin and Liu, Chang and Xie, Guofang},
title = {Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts},
journal = {Allergologia et Immunopathologia},
year = {2024},
doi = {10.15586/aei.v52i4.1111}
}
EUVIMED